We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
VERO | Venus Concept Inc | 1.43 | 0.8433 | 143.74% | 3,728,481 |
VS | Versus Systems Inc | 2.74 | 1.09 | 66.06% | 3,733,352 |
VIRX | Viracta Therapeutics Inc | 0.78 | 0.1451 | 22.85% | 235 |
PRST | Presto Technologies Inc | 0.0911 | 0.0152 | 20.03% | 4,188,283 |
FFIE | Faraday Future Intelligent Electric Inc | 0.6509 | 0.1069 | 19.65% | 7,891,926 |
BTOC | Amlogi Holding Corporation | 5.84 | 0.9402 | 19.19% | 205 |
ESGL | ESGL Holdings Ltd | 1.17 | 0.183 | 18.54% | 9,341 |
TBIO | Telesis Bio Inc | 4.48 | 0.68 | 17.89% | 57 |
GLMD | Galmed Pharmaceuticals Ltd | 0.41 | 0.059 | 16.81% | 1 |
GERN | Geron Corp | 4.49 | 0.60 | 15.42% | 921,135 |
UK | Ucommune International Ltd | 2.25 | 0.30 | 15.38% | 4 |
TORONTO, June 06, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that on June 4, 2024, it was notified by the Nasdaq Stock Market LLC (“Nasdaq”) that the Company had regained compliance with the stockholders’ equity requirement set forth in Nasdaq Listing Rule 5550(b)(1) (“Minimum Equity Requirement”). Pursuant to Nasdaq Listing Rule 5815(d)(4)(B), the Company will be subject to a mandatory panel monitor through June 4, 2025. The Nasdaq Staff originally issued the Company a deficiency notice on May 31, 2023, citing that stockholders’ ...
Tigo MLPE bietet maximale Sicherheit für große gewerbliche und industrielle Solaranlagen in Zentralspanien; zuverlässige Installation dank des Green Glove-Qualitätsprogramms.
Braze (Nasdaq: BRZE) the leading customer engagement platform that empowers brands to Be Absolutely EngagingTM, today announced results for its fiscal quarter ended April 30, 2024.
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that the U.S. Food and Drug Administration (FDA) has approved RYTELO™ (imetelstat) for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent (TD) anemia requiring four or more red blood cell units over eight weeks who have not responded to or have lost response to or are ineligible for erythropoiesis-stimulating agents (ESA).
Rank | Ticker | Board Name | Posts (24h) |
---|---|---|---|
NWBO | NorthWest Biotherapeutics Inc | 251 | |
IGPK | Integrated Cannabis Solutions Inc | 78 | |
RDGL | Vivos Inc | 26 | |
4 | NSAV | NSAV Holding Inc | 54 |
5 | BLEG | Branded Legacy Inc | 54 |
6 | AAPJ | AAP Inc | 33 |
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 71,244.15 | 480.14 | 0.68% | 1.4T | 3,451,405,740 |
ETH | Ethereum | 3,807.59 | -3.68 | -0.10% | 457.81B | 1,644,519,314 |
BNB | Binance Coin | 702.61 | -7.86 | -1.11% | 110.9B | 490,794,322 |
USDT | Tether USD | 0.99937 | -0.00024 | -0.02% | 97.78B | 264,461,327 |
SOL | Solana | 171.49 | 1.54 | 0.91% | 75.74B | 655,365,332 |
STETH | stETH | 3,805.57 | -3.42 | -0.09% | 37.33B | 3,637,049 |
XRP | Ripple | 0.5245 | 0.0031 | 0.59% | 28.61B | 241,364,169 |
USDC | USD Coin | 1.00 | 0.0002 | 0.02% | 28.07B | 911,506,246 |
TONCOIN | Wrapped TON Coin | 7.51 | 0.018417 | 0.25% | 26.07B | 178,662,760 |
DOGE | Dogecoin | 0.16081 | 0.00078 | 0.49% | 23.08B | 242,472,939 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions